Skip to content
Richard Peek
Richard Peek
  • Home
  • Contact Me
  • Publications
  • Richard Peek
← Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate to Severe Ulcerative Colitis
Modeling Human Digestive Diseases with CRISPR-Cas9-modified Organoids →

Correction

Posted on November 23, 2018 by Gastroenterology

Coleman OI, Lobner EM, Bierwirth S, et al. Activated ATF6 induces intestinal dysbiosis and innate immune response to promote colorectal tumorigenesis. Gastroenterology 2018;155:1539–1552.

This entry was posted in News. Bookmark the permalink.
← Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate to Severe Ulcerative Colitis
Modeling Human Digestive Diseases with CRISPR-Cas9-modified Organoids →
  • Links

    • Gastroenterology
    • MyVUMC
  • November 2018
    S M T W T F S
     123
    45678910
    11121314151617
    18192021222324
    252627282930  
    « Oct   Dec »
  • Other websites

    • Etiological Studies of Gastric Carcinoma
    • H. pylori and Gastric Cancer
Richard Peek
Proudly powered by WordPress.